Century Therapeutics Inc — Cash Flow (NASDAQ:IPSC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 89 M14.05 M88.35 M110.14 M 112.02 M Cash from investing activities 298.34 M13.13 M61.13 M47.48 M 115.75 M Cash from financing activities 417.77 M27.16 M9.72 M74.56 M -482 K Free cash flow 44.03 M-16.55 M74.61 M109.98 M 111.03 M

Noticias

TD Cowen inicia cobertura de Century Therapeutics con calificación de compra

TD Cowen inicia cobertura de Century Therapeutics con calificación de Compra

TD Cowen initiates Century Therapeutics stock rating at Buy

Clear Street reitera calificación de Compra para Century Therapeutics a $6.60

Clear Street reitera calificación de Compra para acciones de Century Therapeutics a 6,60 dólares

Oracle, Palantir among market cap stock movers on Monday

Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know

Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler

Clear Street reduce precio objetivo de Century Therapeutics a $6.60

Objetivo de precio de las acciones de Century Therapeutics reducido a 6,60 dólares en Clear Street

Century Therapeutics stock price target lowered to $6.60 at Clear Street

Century Therapeutics obtiene $135 millones en colocación privada